|
Dr. Fong is a well known and well respected entrepreneur and investor in the biotechnology industry. He is the Chairman of Kenson Ventures, LLC. Kenson specializes in venture financing and strategic consulting to biotech companies. As of April 2002, Kenson has 13 investments that fall into 3 major categories: a) Innovative Research Tools, b) Platform Technologies, and c) Drug Development. Prior to founding Kenson, Dr. Fong was the founder and former CEO of CLONTECH Laboratories, that was acquired by Becton Dickinson (BD) in late 1999. CLONTECH is the leader in the Molecular/Cell Biology market, and in the last 4 years before its acquisition, the company experienced an average growth rate of 36% a year. The company also had 48 consecutive quarters of double-digit growth and profits. In 1994, 1995, 1998, and 1999, CLONTECH was selected as one of the fastest-growing companies in the San Francisco Bay Area. Dr. Fong's past experience is best suited for young companies that desire to grow more rapidly. He is also adept at crafting development strategy and realistic implementation plan to promote the long-term growth of company. Dr. Fong obtained his Ph.D. from Indiana University. | 